Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Results from the phase 3 EPCORE DLBCL-1 clinical trial show that patients with relapsed or refractory diffuse large B-cell ...
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result ...
Topline results from a trial evaluating AbbVie and Genmab's epcoritamab to treat a type of lymphoma demonstrated an improvement in progression-free survival, the companies said. AbbVie and Genmab said ...
GlobalData on MSN
Genmab reports top line results in Phase III DLBCL trial
Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting ...
Topline results show that epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, demonstrated an improvement in PFS in patients receiving epcoritamab monotherapy (HR, 0.74; 95 ...
Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...
MERRIMACK — Jacob Miller of Merrimack and a team of 26 other residents, known as Miller’s Crew, will represent the town in the 37th annual Jimmy Fund Walk on Oct. 5. “Every step you take gives ...
A North Huntingdon man who recently celebrated one year in remission from lymphoma is raising money for research into fighting blood cancer. Charles Colletti, 53, a business development manager for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback